glp 1 ra with cvd benefit Glucagon-like peptide receptor agonists: cardiovascular benefits and mechanisms of action GLP-1 receptor agonists and cardiovascular...

Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760

Chem Sci 2025:1 Budzianowska A et al (2025) Antioxidants to defend healthy and youthful skincurrent trends and future directions in cosmetology

Secondary Loss of Response Secondary loss of response means a peptide worked initially, then stopped

Xanthine oxidase and aldehyde oxidase also play a role in the metabolism of drugs and toxins (5)

Measurement of IGF-1 is complicated, by both the biology of IGF-1 and the recent need to differentiate the endogenous form of IGF-1, and the synthetic therapeutic forms developed to treat growth disorders